BR9603911A - Benzoilguanidinas substituídas processo para a sua preparação seu emprego como medicamento ou diagnóstico bem como o medicamento contendo as mesmas - Google Patents
Benzoilguanidinas substituídas processo para a sua preparação seu emprego como medicamento ou diagnóstico bem como o medicamento contendo as mesmasInfo
- Publication number
- BR9603911A BR9603911A BR9603911A BR9603911A BR9603911A BR 9603911 A BR9603911 A BR 9603911A BR 9603911 A BR9603911 A BR 9603911A BR 9603911 A BR9603911 A BR 9603911A BR 9603911 A BR9603911 A BR 9603911A
- Authority
- BR
- Brazil
- Prior art keywords
- medicine
- benzoylguanidines
- diagnosis
- preparation
- well
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
- C07C279/22—Y being a hydrogen or a carbon atom, e.g. benzoylguanidines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Vascular Medicine (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Reproductive Health (AREA)
- Pulmonology (AREA)
- Gastroenterology & Hepatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP95115240A EP0765867A1 (de) | 1995-09-27 | 1995-09-27 | Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Antiarrhytmika oder Diagnostikum sowie sie enthaltendes Medikament |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9603911A true BR9603911A (pt) | 1998-06-09 |
Family
ID=8219659
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9603911A BR9603911A (pt) | 1995-09-27 | 1996-09-26 | Benzoilguanidinas substituídas processo para a sua preparação seu emprego como medicamento ou diagnóstico bem como o medicamento contendo as mesmas |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US5747541A (pt) |
| EP (1) | EP0765867A1 (pt) |
| JP (1) | JPH09124584A (pt) |
| KR (1) | KR970015568A (pt) |
| AR (1) | AR004004A1 (pt) |
| AU (1) | AU6584696A (pt) |
| BR (1) | BR9603911A (pt) |
| CA (1) | CA2186580A1 (pt) |
| CZ (1) | CZ280896A3 (pt) |
| HR (1) | HRP960430A2 (pt) |
| HU (1) | HUP9602640A3 (pt) |
| IL (1) | IL119293A0 (pt) |
| MX (1) | MX9604338A (pt) |
| NO (1) | NO964053L (pt) |
| NZ (1) | NZ299445A (pt) |
| PL (1) | PL315050A1 (pt) |
| SK (1) | SK122596A3 (pt) |
| TR (1) | TR199600753A1 (pt) |
| TW (1) | TW339327B (pt) |
| ZA (1) | ZA968091B (pt) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19859727A1 (de) | 1998-12-23 | 2000-06-29 | Aventis Pharma Gmbh | Die Verwendung von Hemmern des Natrium-Wasserstoff-Austauschers zur Herstellung eines Medikaments zur Verhinderung von altersbedingten Organ-Dysfunktionen, altersbedingten Erkrankungen zur Lebensverlängerung |
| WO2001045716A1 (en) * | 1999-12-20 | 2001-06-28 | Gho'st Holding B.V. | Pharmaceutical composition comprising a physiologically acceptable vanadium compound, salt or complex and a na+/h+ exchange inhibitor |
| US6410563B1 (en) | 1999-12-22 | 2002-06-25 | Merck Frosst Canada & Co. | Substituted 8-arylquinoline phosphodiesterase-4 inhibitors |
| US6639077B2 (en) | 2000-03-23 | 2003-10-28 | Merck Frosst Canada & Co. | Tri-aryl-substituted-ethane PDE4 inhibitors |
| MY123585A (en) * | 2000-03-23 | 2006-05-31 | Merck Canada Inc | Tri-aryl-substituted-ethane pde4 inhibitors. |
| WO2001090076A1 (en) | 2000-05-25 | 2001-11-29 | Merck Frosst Canada & Co. | Fluoroalkoxy-substituted benzamide dichloropyridinyl n-oxide pde4 inhibitor |
| US6740666B2 (en) | 2000-12-20 | 2004-05-25 | Merck & Co., Inc. | Substituted 8-arylquinoline phosphodiesterase-4 inhibitors |
| JP4460221B2 (ja) | 2001-05-24 | 2010-05-12 | メルク フロスト カナダ リミテツド | １−ビアリール−１，８−ナフチリジン−４−オン系ホスホジエステラーゼ−４阻害薬 |
| JO2311B1 (en) | 2001-08-29 | 2005-09-12 | ميرك فروست كندا ليمتد | Alkyl inhibitors Ariel phosphodiesterase-4 |
| ATE486600T1 (de) | 2002-03-12 | 2010-11-15 | Merck Sharp & Dohme | Di-aryl-substituierte tetrazol-modulatoren des metabotropen glutamat-rezeptors-5 |
| US7253218B2 (en) * | 2004-03-01 | 2007-08-07 | H.B. Fuller Company | Sound damping compositions and methods for applying and baking same onto substrates |
| WO2007136636A1 (en) * | 2006-05-17 | 2007-11-29 | Childrens Hospital Los Angeles Research Institute | Drug combinations to treat hyperproliferative disorders |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3780027A (en) * | 1970-04-29 | 1973-12-18 | Merck & Co Inc | Anthranilic acid derivatives |
| DE3929582A1 (de) * | 1989-09-06 | 1991-03-07 | Hoechst Ag | Benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament sowie sie enthaltendes medikament |
| DE59302959D1 (de) * | 1992-02-15 | 1996-07-25 | Hoechst Ag | 3,5-Substituierte Benzoylguanidine, mit antiarrythmischer Wirkung und inhibierender Wirkung auf die Proliferationen von Zellen |
| CZ284456B6 (cs) * | 1992-02-15 | 1998-12-16 | Hoechst Aktiengesellschaft | Aminosubstituované benzoylguanidiny, způsob jejich přípravy, jejich použití jako léčiv a léčivo, které je obsahuje |
| ATE158278T1 (de) * | 1992-02-15 | 1997-10-15 | Hoechst Ag | Ortho-substituierte benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament oder diagnostikum sowie sie enthaltendes medikament |
| ES2097409T3 (es) * | 1992-09-22 | 1997-04-01 | Hoechst Ag | Benzoilguanidinas, procedimiento para su preparacion, asi como su empleo como antiarritmicos. |
| TW250479B (pt) * | 1992-12-15 | 1995-07-01 | Hoechst Ag | |
| TW250477B (pt) * | 1992-12-15 | 1995-07-01 | Hoechst Ag | |
| ATE151071T1 (de) * | 1992-12-16 | 1997-04-15 | Hoechst Ag | 3,5-substituierte aminobenzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament oder diagnostikum sowie sie enthaltendes medikament |
| EP0604852A1 (de) * | 1992-12-28 | 1994-07-06 | Hoechst Aktiengesellschaft | 2,4-Substituierte 5-(N-substituierte-Sulfamoyl)-Benzoylguanidine, als Antiarrythmika, Inhibitoren der Proliferationen von Zellen, und Inhibitoren des Natrium-Protonen-Antiporters |
| ATE157351T1 (de) * | 1993-02-20 | 1997-09-15 | Hoechst Ag | Substituierte benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament, als inhibitoren des zellulären na+/h+-austauschs oder als diagnostikum sowie sie enthaltendes medikament |
| IL109570A0 (en) * | 1993-05-17 | 1994-08-26 | Fujisawa Pharmaceutical Co | Guanidine derivatives, pharmaceutical compositions containing the same and processes for the preparation thereof |
| DE4318658A1 (de) * | 1993-06-04 | 1994-12-08 | Hoechst Ag | Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| DE4318756A1 (de) * | 1993-06-05 | 1994-12-08 | Hoechst Ag | Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| US5372607A (en) * | 1993-06-23 | 1994-12-13 | Medtronic, Inc. | Method and apparatus for monitoring pacemaker intervals |
| DE4325822A1 (de) * | 1993-07-31 | 1995-02-02 | Hoechst Ag | Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| DE4327176C1 (de) * | 1993-08-13 | 1995-01-26 | Metallgesellschaft Ag | Röhrenofen für die Erzeugung kohlenmonoxidhaltiger Gasgemische |
| DE4344550A1 (de) * | 1993-12-24 | 1995-06-29 | Hoechst Ag | Substituierte 1-Oxo-1,2-dihydro-isochinolinoyl- und 1,1-Dioxo-2H-1,2-benzothiazinoylguanidine, Verfahrenzu ihrer Herstellung, ihre Verwendung als Medikamentt oder Diagnostikum sowie sie enthaltendes Medikamen |
| TW415937B (en) * | 1994-01-25 | 2000-12-21 | Hoechst Ag | Phenyl-substituted alkylcarboxylic acid guanidides bearing perfluoroalkyl groups, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| DE4402057A1 (de) * | 1994-01-25 | 1995-08-03 | Hoechst Ag | Perfluoralkylgruppen tragende phenyl-substituierte Alkylcarbonsäure-guanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| DE4417004A1 (de) * | 1994-05-13 | 1995-11-16 | Hoechst Ag | Perfluoralkyl-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| DE4421536A1 (de) * | 1994-06-20 | 1995-12-21 | Hoechst Ag | Perfluoralkylgruppen tragende phenylsubstituierte Alkenylcarbonsäure-guanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| DE4422685A1 (de) * | 1994-06-29 | 1996-01-04 | Hoechst Ag | Ortho-amino-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| DE4432101A1 (de) * | 1994-09-09 | 1996-03-14 | Hoechst Ag | Aminosäure-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| DE4432106A1 (de) * | 1994-09-09 | 1996-03-14 | Hoechst Ag | Mit Heterocyclen-N-Oxid-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum, sie enthaltendes Medikament sowie Zwischenprodukte zu ihrer Herstellung |
| DE4441880A1 (de) * | 1994-11-24 | 1996-05-30 | Hoechst Ag | Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| DE59603311D1 (de) * | 1995-01-30 | 1999-11-18 | Hoechst Ag | Basisch-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
-
1995
- 1995-09-27 EP EP95115240A patent/EP0765867A1/de not_active Withdrawn
- 1995-11-24 TW TW084112529A patent/TW339327B/zh active
-
1996
- 1996-07-01 PL PL96315050A patent/PL315050A1/xx unknown
- 1996-09-25 HR HR95115240.4A patent/HRP960430A2/hr not_active Application Discontinuation
- 1996-09-25 KR KR1019960042324A patent/KR970015568A/ko not_active Application Discontinuation
- 1996-09-25 AR ARP960104498A patent/AR004004A1/es unknown
- 1996-09-25 IL IL11929396A patent/IL119293A0/xx unknown
- 1996-09-25 CZ CZ962808A patent/CZ280896A3/cs unknown
- 1996-09-25 SK SK1225-96A patent/SK122596A3/sk unknown
- 1996-09-25 TR TR96/00753A patent/TR199600753A1/xx unknown
- 1996-09-25 AU AU65846/96A patent/AU6584696A/en not_active Abandoned
- 1996-09-25 NZ NZ299445A patent/NZ299445A/en unknown
- 1996-09-26 BR BR9603911A patent/BR9603911A/pt not_active Application Discontinuation
- 1996-09-26 HU HU9602640A patent/HUP9602640A3/hu unknown
- 1996-09-26 NO NO964053A patent/NO964053L/no unknown
- 1996-09-26 JP JP8254316A patent/JPH09124584A/ja active Pending
- 1996-09-26 MX MX9604338A patent/MX9604338A/es unknown
- 1996-09-26 CA CA002186580A patent/CA2186580A1/en not_active Abandoned
- 1996-09-26 ZA ZA968091A patent/ZA968091B/xx unknown
-
1997
- 1997-06-12 US US08/873,825 patent/US5747541A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| AR004004A1 (es) | 1998-09-30 |
| TR199600753A1 (tr) | 1997-04-22 |
| CA2186580A1 (en) | 1997-03-28 |
| US5747541A (en) | 1998-05-05 |
| HUP9602640A2 (en) | 1997-05-28 |
| NZ299445A (en) | 1997-11-24 |
| MX9604338A (es) | 1997-03-29 |
| IL119293A0 (en) | 1996-12-05 |
| HU9602640D0 (en) | 1996-11-28 |
| CZ280896A3 (en) | 1997-06-11 |
| HUP9602640A3 (en) | 1997-11-28 |
| SK122596A3 (en) | 1997-05-07 |
| KR970015568A (ko) | 1997-04-28 |
| PL315050A1 (en) | 1997-04-01 |
| NO964053L (no) | 1997-04-01 |
| EP0765867A1 (de) | 1997-04-02 |
| HRP960430A2 (en) | 1998-02-28 |
| AU6584696A (en) | 1997-04-10 |
| JPH09124584A (ja) | 1997-05-13 |
| NO964053D0 (no) | 1996-09-26 |
| ZA968091B (en) | 1997-03-27 |
| TW339327B (en) | 1998-09-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9605417A (pt) | Sulfonimidamidas substituídas processos para a sua preparação seu emprego como medicamento ou diagnóstico bem como o medicamento contendo as mesmas | |
| BR9005093A (pt) | Tampao,em especial para a higiene de senhoras,bem como processo e dispositivo para a fabricacao do mesmo | |
| BR8304862A (pt) | "n-piridinossulfonil-n"-piridinil-e-triazinilureias,processo para sua preparacao,piridinossulfonamidas,piridinossulfonilisocianatos-tiacianatos-e-carbamatos,processo para a preparacao de sais de audicao,composicao herbicida e emprego | |
| PT94956A (pt) | Processo para a preparacao de azois com actividade pesticida | |
| DE69017387D1 (de) | Verbesserungen für Blutentnahmegeräte. | |
| PT91864A (pt) | Processo de preparacao de dieteres utilizaveis na preparacao de catalisadores de ziegler-natta | |
| DE69331228T2 (de) | Heilmittel für thrombozytopenia | |
| PT1222163E (pt) | 1,1-bifenil-2-carboxamidas substituidas na posicao 2 processo para a sua preparacao, sua utilizacao como medicamento, bem como preparacoes farmaceuticas contendo estas | |
| BR9603911A (pt) | Benzoilguanidinas substituídas processo para a sua preparação seu emprego como medicamento ou diagnóstico bem como o medicamento contendo as mesmas | |
| DE9321547U1 (de) | Spritze für medzinische Zwecke | |
| BR9105406A (pt) | Benzodiazepinonas,compostos,cetonas,processo para a preparacao de compostos,medicamento e uso | |
| BR9602394A (pt) | Guanididas de ácido alquenilcarboxílico processo para a sua preparação seus usos método para o tratamento de arritmias bem como medicamento | |
| BR9703338A (pt) | 2-Naftoil guanidinas substituídas processo para a sua preparaçao sua aplicaçao como medicamento ou diagnóstico bem como medicamento que as contêm | |
| DE69029546T2 (de) | Ein Diagnosesystem | |
| NO960364D0 (no) | Basisk-substituerte benzolguanidiner, fremgangsmåte for fremstilling derav, deres anvendelse som medikament eller diagnostikum samt medikament inneholdende forbindelsen | |
| BR9600778A (pt) | Benzenossulfoniluréia e - tiouréla substituida processo para sua preparação seu uso e medicamento | |
| BR9703440A (pt) | Benzoilguadinas orto-substituídas processos para sua preparação seu emprego como medicamento ou diagnóstico bem como medicamento contendo as mesmas | |
| BR9703617A (pt) | Benzoilguanidinas orto-substituídas processo para a sua preparação seu emprego como medicamento ou diagnóstico bem como medicamento contendo as mesmas | |
| BR9605568A (pt) | Benzoilguanidinas substituídas por sulfonilamino processo para a sua preparaçao seu emprego como medicamento ou diagnóstico bem como o medicamento contendo as mesmas | |
| BR8907663A (pt) | Processo para a desinfeccao de massas de moldagem medicas | |
| BR8901036A (pt) | Compostos,processo para sua preparacao,bem como sua aplicacao | |
| BR9703342A (pt) | 1-Naftoil guanidinas substituídas processo para a sua preparaçao sua aplicaçao como medicamento ou diagnóstico bem como medicamento que as contêm | |
| BR9600370A (pt) | Benzenossulfoniluréias e-tiouréias substituídas processo para a sua preparação seus usos e medicamento contendo as mesmas | |
| BR9603112A (pt) | Benzoilguanidinas processo para a sua preparação seu uso e medicamento | |
| BR9703326A (pt) | Benzoilguadinas bis-orto-substituídas processo para a sua preparação sua aplicação como medicamento ou diagnóstico bem como medicamento que as contêm |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA10 | Dismissal: dismissal - article 33 of industrial property law |